Reopro removal during cardiopulmonary bypass using a hemoconcentrator

J Thorac Cardiovasc Surg. 1999 May;117(5):1032-4. doi: 10.1016/S0022-5223(99)70392-2.

Authors

M Poullis¹, R Manning, D Haskard, K Taylor

Affiliation

¹ Department of Cardiothoracic Surgery, Hammersmith Hospital, London, United Kingdom.

PMID: 10220706
DOI: 10.1016/S0022-5223(99)70392-2

No abstract available

Publication types

Comparative Study

MeSH terms

Abciximab
Antibodies, Monoclonal / isolation & purification*
Blood Loss, Surgical / prevention & control
Cardiac Surgical Procedures / adverse effects
Cardiopulmonary Bypass*
Hemofiltration / methods*
Humans
Immunoglobulin Fab Fragments / isolation & purification*
Platelet Aggregation
Platelet Aggregation Inhibitors / isolation & purification*
Postoperative Hemorrhage / blood
Postoperative Hemorrhage / chemically induced
Postoperative Hemorrhage / prevention & control

Substances

Antibodies, Monoclonal
Immunoglobulin Fab Fragments
Platelet Aggregation Inhibitors
Abciximab